Is ANORF or MRK a better dividend investment in 2026?

ANORF currently yields 4000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: ANORF offers higher current income.

What is the dividend yield difference between ANORF and MRK?

ANORF has a forward dividend yield of 4000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 3997.24 percentage points.

Home › Compare › ANORF vs MRK

ANORF vs MRK: Dividend Comparison 2026

ANORF yields 4000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ANORF wins by $7175340620755.81M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ANORF

● Live price

4000.00%

Share price

$0.05

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7175340620755.87M

Annual income

$6,839,006,593,197,835,000.00

Full ANORF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — ANORF vs MRK

📍 ANORF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ANORF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ANORF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ANORF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ANORF

Annual income on $10K today (after 15% tax)

$340,000.00/yr

After 10yr DRIP, annual income (after tax)

$5,813,155,604,218,160,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, ANORF beats the other by $5,813,155,604,218,152,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ANORF + MRK for your $10,000?

ANORF: 50%MRK: 50%

100% MRK50/50100% ANORF

Portfolio after 10yr

$3587670310377.96M

Annual income

$3,419,503,296,598,923,000.00/yr

Blended yield

95.31%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ANORF

No analyst data

Altman Z

1248.8

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ANORF buys

MRK buys

No recent congressional trades found for ANORF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricANORFMRK

Forward yield	4000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$7175340620755.87M ✓	$56.8K
Annual income after 10y	$6,839,006,593,197,835,000.00 ✓	$9,798.13
Total dividends collected	$7152397773804.84M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: ANORF vs MRK ($10,000, DRIP)

Year	ANORF Portfolio	ANORF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$410,700	$400,000.00	$11,206	$366.19	+$399.5K → ANORF
2	$15,792,720	$15,353,271.03	$12,650	$502.35	+$15.78M → ANORF
3	$568,657,142	$551,758,931.89	$14,407	$694.19	+$568.64M → ANORF
4	$19,176,207,860	$18,567,744,718.20	$16,585	$967.82	+$19176.19M → ANORF
5	$605,696,028,890	$585,177,486,479.73	$19,342	$1,363.89	+$605696.01M → ANORF
6	$17,922,210,653,594	$17,274,115,902,681.27	$22,913	$1,947.19	+$17922210.63M → ANORF
7	$496,869,793,504,300	$477,693,028,104,954.00	$27,662	$2,823.89	+$496869793.48M → ANORF
8	$12,908,672,105,251,704	$12,377,021,426,202,104.00	$34,159	$4,173.35	+$12908672105.22M → ANORF
9	$314,330,866,876,668,540	$300,518,587,724,049,200.00	$43,337	$6,308.80	+$314330866876.63M → ANORF
10	$7,175,340,620,755,871,000	$6,839,006,593,197,835,000.00	$56,776	$9,798.13	+$7175340620755.81M → ANORF

ANORF vs MRK: Complete Analysis 2026

ANORF — Stock

AnorTech Inc. engages in the acquisition, exploration, development, and mining of mineral resources in Canada and Greenland. The company holds 100% interest in the Gronne Bjerg anorthosite project located in Greenland. It also produces anorthosite mineral products, such as waste-free alumina, CO2 free cement, and concrete thermal energy storage systems. The company was formerly known as Hudson Resources Inc. and changed its name to AnorTech Inc. in March 2024. AnorTech Inc. was incorporated in 2000 and is headquartered in Vancouver, Canada.

Full ANORF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this ANORF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ANORF vs SCHD ANORF vs JEPI ANORF vs O ANORF vs KO ANORF vs MAIN ANORF vs JNJ ANORF vs ABBV ANORF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.